Validation of plasma amyloid-β 42/40 for detecting Alzheimer disease amyloid plaques

Y Li, SE Schindler, JG Bollinger, V Ovod… - Neurology, 2022 - AAN Enterprises
Background and Objectives To determine the diagnostic accuracy of a plasma Aβ42/Aβ40
assay in classifying amyloid PET status across global research studies using samples …
被引用次数：137 相关文章

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

Y Li, SE Schindler, JG Bollinger, V Ovod… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and objectives To determine the diagnostic accuracy of a plasma Aβ42/Aβ40
assay in classifying amyloid PET status across global research studies using samples …

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

Y Li, SE Schindler, JG Bollinger, V Ovod… - Neurology, 2022 - lup.lub.lu.se
Background and Objectives To determine the diagnostic accuracy of a plasma Aβ42/Aβ40
assay in classifying amyloid PET status across global research studies using samples …

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

Y Li, SE Schindler, JG Bollinger, V Ovod… - …, 2022 - ingentaconnect.com
Background and Objectives To determine the diagnostic accuracy of a plasma Aβ42/Aβ40
assay in classifying amyloid PET status across global research studies using samples …
[HTML] nih.gov

[HTML][HTML] Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

Y Li, SE Schindler, JG Bollinger, V Ovod… - Neurology, 2022 - ncbi.nlm.nih.gov
Methods Plasma samples (n= 465) were obtained from 3 large Alzheimer disease (AD)
research cohorts in the United States (n= 182), Australia (n= 183), and Sweden (n= 100) …

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques.

Y Li, SE Schindler, JG Bollinger, V Ovod… - Neurology, 2021 - europepmc.org
Methods Plasma samples (n= 465) were obtained from 3 large Alzheimer disease (AD)
research cohorts in the United States (n= 182), Australia (n= 183), and Sweden (n= 100) …

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

Y Li, SE Schindler, JG Bollinger, V Ovod… - …, 2022 - portal.research.lu.se
Abstract Background and Objectives To determine the diagnostic accuracy of a plasma
Aβ42/Aβ40 assay in classifying amyloid PET status across global research studies using …

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

Y Li, SE Schindler, JG Bollinger, V Ovod… - Neurology, 2022 - profiles.wustl.edu
Abstract Background and Objectives To determine the diagnostic accuracy of a plasma
Aβ42/Aβ40 assay in classifying amyloid PET status across global research studies using …

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques.

Y Li, S Schindler, J Bollinger, V Ovod, K Mawuenyega… - Neurology, 2022 - escholarship.org
BACKGROUND AND OBJECTIVES: To determine the diagnostic accuracy of a plasma
Aβ42/Aβ40 assay in classifying amyloid PET status across global research studies using …

Validation of plasma amyloid-β 42/40 for detecting Alzheimer disease amyloid plaques

Y Li, SE Schindler, JG Bollinger, V Ovod… - 2022 - ro.ecu.edu.au
METHODS: Plasma samples (n= 465) were obtained from 3 large Alzheimer disease (AD)
research cohorts in the United States (n= 182), Australia (n= 183), and Sweden (n= 100) …